Gubra A/S
GUBRA | CO
Overview
Corporate Details
- ISIN(s):
- DK0062266474
- LEI:
- 254900T17RRFZONO6W53
- Country:
- Denmark
- Address:
- Hørsholm Kongevej 11 B, 2970 Hørsholm
- Website:
- https://www.gubra.dk/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra’s activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of development milestone payments and potential royalties from the D&P business.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Vivoryon Therapeutics N.V. | Germany | VVY | |
|
Vytrus Biotech S.A. | Spain | VYT | |
|
WntResearch AB | Sweden | WNT | |
|
Xbrane Biopharma | Sweden | XBRANE | |
|
Xintela AB | Sweden | XINT | |
|
XTL Biopharmaceuticals Ltd. | Israel | XTLB | |
|
Zealand Pharma | Denmark | ZEAL | |
|
Zelluna ASA | Norway | ULTI | |
|
Zephyrus Wing Energies Ltd. | Israel | ZPRS | |
|
Ziccum AB | Sweden | ZICC |